There is much to be learnt about the costs of multiple sclerosis in Latin America

Detalhes bibliográficos
Autor(a) principal: Romano,Marina
Data de Publicação: 2013
Outros Autores: Machnicki,Gerardo, Rojas,Juan Ignacio, Frider,Nadina, Correale,Jorge
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de neuro-psiquiatria (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000800549
Resumo: METHOD: A systematic review of the literature from 1990 to 2011 was conducted. Outcome measures included: mean cost of disease modifying therapies (DMTs), mean cost of treatment of relapses and mean cost of disease by stage stratification measured by the expanded disability status scale (EDSS). RESULTS: Seven studies from three countries (Brazil, Argentina and Colombia) were included. In 2004, in Argentina, the mean cost of DMT treatment was reported to be USD 35,000 per patient treated. In Brazil, the total MS expenditure of DMTs rose from USD 14,011,700 in 2006 to USD 122,575,000 in 2009. Patient costs ranged between USD 10,543 (EDSS 8-9.5) and USD 25,713 (EDSS 3-5.5). Indirect costs markedly increased for the EDSS 8-9.5 patients. CONCLUSION: Further research assessing the economic burden of MS in LA is warranted.
id ABNEURO-1_9b07db3236ef85e731683e52796761e8
oai_identifier_str oai:scielo:S0004-282X2013000800549
network_acronym_str ABNEURO-1
network_name_str Arquivos de neuro-psiquiatria (Online)
repository_id_str
spelling There is much to be learnt about the costs of multiple sclerosis in Latin Americamultiple sclerosisLatin Americacostscost analysis METHOD: A systematic review of the literature from 1990 to 2011 was conducted. Outcome measures included: mean cost of disease modifying therapies (DMTs), mean cost of treatment of relapses and mean cost of disease by stage stratification measured by the expanded disability status scale (EDSS). RESULTS: Seven studies from three countries (Brazil, Argentina and Colombia) were included. In 2004, in Argentina, the mean cost of DMT treatment was reported to be USD 35,000 per patient treated. In Brazil, the total MS expenditure of DMTs rose from USD 14,011,700 in 2006 to USD 122,575,000 in 2009. Patient costs ranged between USD 10,543 (EDSS 8-9.5) and USD 25,713 (EDSS 3-5.5). Indirect costs markedly increased for the EDSS 8-9.5 patients. CONCLUSION: Further research assessing the economic burden of MS in LA is warranted. Academia Brasileira de Neurologia - ABNEURO2013-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000800549Arquivos de Neuro-Psiquiatria v.71 n.8 2013reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/0004-282X20130082info:eu-repo/semantics/openAccessRomano,MarinaMachnicki,GerardoRojas,Juan IgnacioFrider,NadinaCorreale,Jorgeeng2013-08-26T00:00:00Zoai:scielo:S0004-282X2013000800549Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2013-08-26T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse
dc.title.none.fl_str_mv There is much to be learnt about the costs of multiple sclerosis in Latin America
title There is much to be learnt about the costs of multiple sclerosis in Latin America
spellingShingle There is much to be learnt about the costs of multiple sclerosis in Latin America
Romano,Marina
multiple sclerosis
Latin America
costs
cost analysis
title_short There is much to be learnt about the costs of multiple sclerosis in Latin America
title_full There is much to be learnt about the costs of multiple sclerosis in Latin America
title_fullStr There is much to be learnt about the costs of multiple sclerosis in Latin America
title_full_unstemmed There is much to be learnt about the costs of multiple sclerosis in Latin America
title_sort There is much to be learnt about the costs of multiple sclerosis in Latin America
author Romano,Marina
author_facet Romano,Marina
Machnicki,Gerardo
Rojas,Juan Ignacio
Frider,Nadina
Correale,Jorge
author_role author
author2 Machnicki,Gerardo
Rojas,Juan Ignacio
Frider,Nadina
Correale,Jorge
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Romano,Marina
Machnicki,Gerardo
Rojas,Juan Ignacio
Frider,Nadina
Correale,Jorge
dc.subject.por.fl_str_mv multiple sclerosis
Latin America
costs
cost analysis
topic multiple sclerosis
Latin America
costs
cost analysis
description METHOD: A systematic review of the literature from 1990 to 2011 was conducted. Outcome measures included: mean cost of disease modifying therapies (DMTs), mean cost of treatment of relapses and mean cost of disease by stage stratification measured by the expanded disability status scale (EDSS). RESULTS: Seven studies from three countries (Brazil, Argentina and Colombia) were included. In 2004, in Argentina, the mean cost of DMT treatment was reported to be USD 35,000 per patient treated. In Brazil, the total MS expenditure of DMTs rose from USD 14,011,700 in 2006 to USD 122,575,000 in 2009. Patient costs ranged between USD 10,543 (EDSS 8-9.5) and USD 25,713 (EDSS 3-5.5). Indirect costs markedly increased for the EDSS 8-9.5 patients. CONCLUSION: Further research assessing the economic burden of MS in LA is warranted.
publishDate 2013
dc.date.none.fl_str_mv 2013-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000800549
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000800549
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0004-282X20130082
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
dc.source.none.fl_str_mv Arquivos de Neuro-Psiquiatria v.71 n.8 2013
reponame:Arquivos de neuro-psiquiatria (Online)
instname:Academia Brasileira de Neurologia
instacron:ABNEURO
instname_str Academia Brasileira de Neurologia
instacron_str ABNEURO
institution ABNEURO
reponame_str Arquivos de neuro-psiquiatria (Online)
collection Arquivos de neuro-psiquiatria (Online)
repository.name.fl_str_mv Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia
repository.mail.fl_str_mv ||revista.arquivos@abneuro.org
_version_ 1754212775225196544

Registros relacionados